Alon Ruth has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 9091 shares of Silexion Therapeutics Corp ($SLXN) on February 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Silexion Therapeutics Corp | $SLXN | Alon Ruth | Director | A | Ordinary Shares | 9091 | $0.00 | 10,228.0000 | 3,126,642 | 799.56% | 0.29% |
| Feb. 20, 2026 | Silexion Therapeutics Corp | $SLXN | Alon Ruth | Director | A | Stock Option (right to buy Ordinary Shares) | 10685 | $0.00 | 11,620.0000 | 3,126,642 | 1142.78% | 0.34% |
| Feb. 9, 2025 | Silexion Therapeutics Corp | $SLXN | Alon Ruth | Director | A | Ordinary Shares | 794 | $0.00 | 1,197.0000 | 8,414,615,000 | 197.02% | 0.00% |
| Feb. 9, 2025 | Silexion Therapeutics Corp | $SLXN | Alon Ruth | Director | A | Stock Option (right to buy ordinary shares) | 935 | $0.00 | 935.0000 | 8,414,615,000 | 9999.99% | 0.00% |